U.K. Becomes First Country to Approve a CRISPR Disease Treatment

A newly approved CRISPR therapy could transform the treatment of sickle cell disease and beta-thalassemia—but the technology is expensive

https://www.scientificamerican.com/article/u-k-becomes-first-country-to-approve-a-crispr-disease-treatment/

Reply to this note

Please Login to reply.

Discussion

No replies yet.